Literature DB >> 18393605

Feasibility of global measles eradication after interruption of transmission in the Americas.

Ciro A de Quadros1, Jon Kim Andrus, M Carolina Danovaro-Holliday, Carlos Castillo-Solórzano.   

Abstract

Measles is one of the most infectious diseases. Before the introduction of the measles vaccine, nearly all children contracted measles. By the end of the 1980s, most countries of the world had incorporated the measles vaccine into their routine vaccination programs. Globally, some 345,000 deaths due to measles still occur every year. Eradication of measles would play an important role in improving child survival. The goal to eradicate measles from the Americas was set by the Pan-American Sanitary Conference in 1994. Progress to date has been remarkable. Measles is no longer an endemic disease in the Americas and interruption of transmission has been documented in most countries. As of December 2007, 5 years have elapsed since the detection of the last endemic case in Venezuela in November 2002. This experience demonstrates that interruption of measles transmission can be achieved and sustained over a long period of time. Global eradication should be feasible if the appropriate strategies are implemented. Even in a new paradigm in which eradication is not followed by the discontinuation of vaccination, eradication of measles should be a good investment to avoid expensive epidemics and save those children that would potentially die due to infection with the measles virus. It is not only a dream to think that we will see a world free of measles by the year 2015.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393605     DOI: 10.1586/14760584.7.3.355

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  6 in total

1.  Global rinderpest eradication: lessons learned and why humans should celebrate too.

Authors:  David M Morens; Edward C Holmes; A Sally Davis; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2011-06-07       Impact factor: 5.226

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

3.  Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China.

Authors:  Yongzhen Xiong; Dong Wang; Weiyan Lin; Hao Tang; Shaoli Chen; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2014-01-21       Impact factor: 3.452

Review 4.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

Review 5.  Measles control--can measles virus inhibitors make a difference?

Authors:  Richard K Plemper; James P Snyder
Journal:  Curr Opin Investig Drugs       Date:  2009-08

6.  Vaccination Week in the Americas: an opportunity to integrate other health services with immunization.

Authors:  Alba Maria Ropero-Álvarez; Hannah J Kurtis; M Carolina Danovaro-Holliday; Cuauhtémoc Ruiz-Matus; Gina Tambini
Journal:  J Infect Dis       Date:  2012-03       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.